Next Article in Journal
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis
Next Article in Special Issue
Identifying Cellular Stress-Related mRNA Changes Induced by Novel Xanthone Derivatives in Ovarian Cancer Cells In Vitro
Previous Article in Journal
Novel Lipid-Based Formulation to Enhance Coenzyme Q10 Bioavailability: Preclinical Assessment and Phase 1 Pharmacokinetic Trial
Previous Article in Special Issue
Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(4), 415; https://doi.org/10.3390/pharmaceutics17040415
Action Date Notes Link
article xml file uploaded 25 March 2025 13:09 CET Original file -
article xml uploaded. 25 March 2025 13:09 CET Update https://www.mdpi.com/1999-4923/17/4/415/xml
article pdf uploaded. 25 March 2025 13:09 CET Version of Record https://www.mdpi.com/1999-4923/17/4/415/pdf
article supplementary file uploaded. 25 March 2025 13:09 CET - https://www.mdpi.com/1999-4923/17/4/415#supplementary
article html file updated 25 March 2025 13:13 CET Original file -
article html file updated 24 June 2025 21:38 CEST Update https://www.mdpi.com/1999-4923/17/4/415/html
Back to TopTop